CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 132 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,579,190 | -31.3% | 393,000 | 0.0% | 0.57% | -23.6% |
| Q2 2023 | $12,493,470 | +30.3% | 393,000 | 0.0% | 0.75% | +7.5% |
| Q1 2023 | $9,585,270 | -22.7% | 393,000 | 0.0% | 0.69% | -10.0% |
| Q4 2022 | $12,395,220 | +11.6% | 393,000 | 0.0% | 0.77% | -9.8% |
| Q3 2022 | $11,106,000 | +107.7% | 393,000 | +94.3% | 0.86% | +69.3% |
| Q2 2022 | $5,348,000 | +173.6% | 202,260 | +262.2% | 0.50% | +202.4% |
| Q1 2022 | $1,955,000 | – | 55,835 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |